Classical swine fever (CSF) marker vaccine - Trial III. Evaluation of discriminatory ELISAs

被引:59
作者
Floegel-Niesmann, G [1 ]
机构
[1] EU Reference Lab CSF, Hannover Sch Vet Med, Inst Virol, D-30559 Hannover, Germany
关键词
pig-viruses; classical swine fever virus; marker vaccine; discriminatory ELISA; sensitivity; specificity;
D O I
10.1016/S0378-1135(01)00411-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The objective of the marker vaccine trial was to test the two available CSF marker vaccines in scenarios which are likely to occur in the field and to evaluate the reliability of the discriminatory tests. The evaluation of the discriminatory tests was of special importance because there is no requirement for formal data concerning their performance by the European Medicinal Products Evaluation Agency (EMEA) in London. EMEA is responsible for the licensing procedure of the marker vaccines within the EU. Sixteen National Swine Fever Laboratories (NSFL) participated in testing the discriminatory ELISAs. They were tested for sensitivity, specificity, reproducibility and practicability. Reference sera (CSFV and BVDV antibody positive) and field sera were used as well as sera from the weaner and sow experiments produced during the marker vaccine trial. Both discriminatory ELISAs were less sensitive than conventional CSF antibody ELISAs, although there was considerable variation between them. Both discriminatory ELISA was less specific than the other, but more sensitive, and vice versa. Neither discriminatory ELISA consistently detected the marker-vaccinated, CSF-cballenged weaner pigs correctly as 'CSF positive', although CSF-challenged pregnant sows were identified correctly. The limitations of the discriminatory ELISAs used in the trial was the major factor that would prevent the use of these two marker vaccines under emergency field conditions. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:121 / 136
页数:16
相关论文
共 48 条
[1]   Genetic typing of classical swine fever virus isolates from the territory of the Czech Republic [J].
Bartak, P ;
Greiser-Wilke, I .
VETERINARY MICROBIOLOGY, 2000, 77 (1-2) :59-70
[2]   Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus [J].
Bouma, A ;
De Smit, AJ ;
De Jong, MCM ;
De Kluijver, EP ;
Moormann, RJM .
VACCINE, 2000, 18 (14) :1374-1381
[3]   Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus [J].
Bouma, A ;
de Smit, AJ ;
de Kluijver, EP ;
Terpstra, C ;
Moormann, RJM .
VETERINARY MICROBIOLOGY, 1999, 66 (02) :101-114
[4]   An improved ELISA for the detection of serum antibodies directed against classical swine fever virus [J].
Colijn, EO ;
Bloemraad, M ;
Wensvoort, G .
VETERINARY MICROBIOLOGY, 1997, 59 (01) :15-25
[5]  
DAHLE J, 1995, BERL MUNCH TIERARZTL, V108, P20
[6]  
DAHLE J, 1995, WIEN TIERARZTL MONAT, V82, P232
[7]  
DAHLE J, 1987, DEUT TIERARZTL WOCH, V94, P590
[8]  
de Smit A.J., 2000, CLASSICAL SWINE FEVE, P117
[9]   Laboratory decision-making during the classical swine fever epidemic of 1997-1998 in The Netherlands [J].
de Smit, AJ ;
Eblé, PL ;
de Kluijver, EP ;
Bloemraad, M ;
Bouma, A .
PREVENTIVE VETERINARY MEDICINE, 1999, 42 (3-4) :185-199
[10]   EXPERIMENTAL QUANTIFICATION OF VACCINE-INDUCED REDUCTION IN VIRUS TRANSMISSION [J].
DEJONG, MCM ;
KIMMAN, TG .
VACCINE, 1994, 12 (08) :761-766